CA1129881A - Benzamidoalkyl mercaptans - Google Patents
Benzamidoalkyl mercaptansInfo
- Publication number
- CA1129881A CA1129881A CA333,426A CA333426A CA1129881A CA 1129881 A CA1129881 A CA 1129881A CA 333426 A CA333426 A CA 333426A CA 1129881 A CA1129881 A CA 1129881A
- Authority
- CA
- Canada
- Prior art keywords
- alk
- acid
- formula
- reacting
- alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 title abstract description 9
- -1 amino, carboxy Chemical group 0.000 claims abstract description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 6
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 150000002367 halogens Chemical group 0.000 claims abstract description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 29
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 11
- 150000002148 esters Chemical class 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 7
- TWTVLBCKCXYHPV-UHFFFAOYSA-N 4-chloro-n-(2-sulfanylethyl)benzamide Chemical compound SCCNC(=O)C1=CC=C(Cl)C=C1 TWTVLBCKCXYHPV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- YGAPOICUMNPIPF-UHFFFAOYSA-N 4-methoxybenzenecarbothioic s-acid Chemical compound COC1=CC=C(C(S)=O)C=C1 YGAPOICUMNPIPF-UHFFFAOYSA-N 0.000 claims description 5
- PJHWTWHVCOZCPU-UHFFFAOYSA-N 4-methylbenzenecarbothioic s-acid Chemical compound CC1=CC=C(C(O)=S)C=C1 PJHWTWHVCOZCPU-UHFFFAOYSA-N 0.000 claims description 5
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 5
- XRHGYUZYPHTUJZ-UHFFFAOYSA-N 4-chlorobenzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1 XRHGYUZYPHTUJZ-UHFFFAOYSA-N 0.000 claims description 3
- ZWUHJFCTWYZUIY-UHFFFAOYSA-N 4-methoxy-n-(2-sulfanylethyl)benzamide Chemical compound COC1=CC=C(C(=O)NCCS)C=C1 ZWUHJFCTWYZUIY-UHFFFAOYSA-N 0.000 claims description 3
- VGHWCTAIXNVUJL-UHFFFAOYSA-N 4-methyl-n-(2-sulfanylethyl)benzamide Chemical compound CC1=CC=C(C(=O)NCCS)C=C1 VGHWCTAIXNVUJL-UHFFFAOYSA-N 0.000 claims description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 210000003097 mucus Anatomy 0.000 abstract description 8
- 239000003172 expectorant agent Substances 0.000 abstract description 3
- 229940066491 mucolytics Drugs 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 230000000510 mucolytic effect Effects 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229910001868 water Inorganic materials 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010037368 Pulmonary congestion Diseases 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- HMDHOFNCICZZPD-UHFFFAOYSA-N 3,4-dimethylbenzenecarbothioic s-acid Chemical compound CC1=CC=C(C(O)=S)C=C1C HMDHOFNCICZZPD-UHFFFAOYSA-N 0.000 description 2
- NQUVCRCCRXRJCK-UHFFFAOYSA-N 4-methylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C=C1 NQUVCRCCRXRJCK-UHFFFAOYSA-N 0.000 description 2
- 125000006414 CCl Chemical group ClC* 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 2
- UIJGNTRUPZPVNG-UHFFFAOYSA-N benzenecarbothioic s-acid Chemical compound SC(=O)C1=CC=CC=C1 UIJGNTRUPZPVNG-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- VQLAUZQBHULEDZ-UHFFFAOYSA-N n-(2-sulfanylethyl)benzamide Chemical compound SCCNC(=O)C1=CC=CC=C1 VQLAUZQBHULEDZ-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- LGDQCFHYSGLOKP-UHFFFAOYSA-N 1-sulfanylpropan-2-ylazanium;chloride Chemical compound Cl.CC(N)CS LGDQCFHYSGLOKP-UHFFFAOYSA-N 0.000 description 1
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 1
- MRPINLYTPGPSAX-UHFFFAOYSA-N 3,4,5-trichloro-N-(2-sulfanylethyl)benzamide Chemical compound ClC=1C=C(C(=O)NCCS)C=C(C1Cl)Cl MRPINLYTPGPSAX-UHFFFAOYSA-N 0.000 description 1
- ICUICNRYLHKQGS-UHFFFAOYSA-N 3,4,5-trichlorobenzoic acid Chemical compound OC(=O)C1=CC(Cl)=C(Cl)C(Cl)=C1 ICUICNRYLHKQGS-UHFFFAOYSA-N 0.000 description 1
- NQKUVVLYLMBAEP-UHFFFAOYSA-N 3,4,5-trimethoxybenzenecarbothioic s-acid Chemical compound COC1=CC(C(S)=O)=CC(OC)=C1OC NQKUVVLYLMBAEP-UHFFFAOYSA-N 0.000 description 1
- RGAKSNQOIIYQRM-UHFFFAOYSA-N 3,4-dimethylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C=C1C RGAKSNQOIIYQRM-UHFFFAOYSA-N 0.000 description 1
- OQVKGSDRYMYQKF-UHFFFAOYSA-N 3-(trifluoromethyl)benzenecarbothioic s-acid Chemical compound OC(=S)C1=CC=CC(C(F)(F)F)=C1 OQVKGSDRYMYQKF-UHFFFAOYSA-N 0.000 description 1
- RUJYJCANMOTJMO-UHFFFAOYSA-N 3-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC(C(Cl)=O)=C1 RUJYJCANMOTJMO-UHFFFAOYSA-N 0.000 description 1
- GMEDUXHKSSWXSL-UHFFFAOYSA-N 3-sulfanylpropylazanium;chloride Chemical compound Cl.NCCCS GMEDUXHKSSWXSL-UHFFFAOYSA-N 0.000 description 1
- PWCDFLBEHVHREU-UHFFFAOYSA-N 4-(2-sulfanylethylcarbamoyl)benzoic acid Chemical compound C(=O)(O)C1=CC=C(C(=O)NCCS)C=C1 PWCDFLBEHVHREU-UHFFFAOYSA-N 0.000 description 1
- QIKYZXDTTPVVAC-UHFFFAOYSA-N 4-Aminobenzamide Chemical compound NC(=O)C1=CC=C(N)C=C1 QIKYZXDTTPVVAC-UHFFFAOYSA-N 0.000 description 1
- SYRDMPUJUIXSPL-UHFFFAOYSA-N 4-amino-N-(2-sulfanylethyl)benzamide Chemical compound SCCNC(C1=CC=C(C=C1)N)=O SYRDMPUJUIXSPL-UHFFFAOYSA-N 0.000 description 1
- TUXYZHVUPGXXQG-UHFFFAOYSA-N 4-bromobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1 TUXYZHVUPGXXQG-UHFFFAOYSA-N 0.000 description 1
- OYEQKMASMPBQMP-UHFFFAOYSA-N 4-carbonochloridoylbenzoic acid Chemical compound OC(=O)C1=CC=C(C(Cl)=O)C=C1 OYEQKMASMPBQMP-UHFFFAOYSA-N 0.000 description 1
- ZVBPESUQUNYBBZ-UHFFFAOYSA-N 4-chloro-N-(3-sulfanylpropyl)benzamide Chemical compound ClC1=CC=C(C(=O)NCCCS)C=C1 ZVBPESUQUNYBBZ-UHFFFAOYSA-N 0.000 description 1
- ZGWQSLHLLDAMNS-UHFFFAOYSA-N 4-methoxy-N-(3-sulfanylpropyl)benzamide Chemical compound COC1=CC=C(C(=O)NCCCS)C=C1 ZGWQSLHLLDAMNS-UHFFFAOYSA-N 0.000 description 1
- DTVKYSKUTKSXJJ-UHFFFAOYSA-N 4-methyl-N-(3-sulfanylpropyl)benzamide Chemical compound CC1=CC=C(C(=O)NCCCS)C=C1 DTVKYSKUTKSXJJ-UHFFFAOYSA-N 0.000 description 1
- TXTGBKDPANLZJK-UHFFFAOYSA-N 4-sulfanylcarbonylbenzoic acid Chemical compound OC(=O)C1=CC=C(C(O)=S)C=C1 TXTGBKDPANLZJK-UHFFFAOYSA-N 0.000 description 1
- RDGGNBINXAQCJN-UHFFFAOYSA-N C(C)S.NC1=CC=C(C(=O)N)C=C1 Chemical compound C(C)S.NC1=CC=C(C(=O)N)C=C1 RDGGNBINXAQCJN-UHFFFAOYSA-N 0.000 description 1
- QQIYDJPNFUIQMI-UHFFFAOYSA-N CC=1C=C(C(=O)NCCS)C=CC1C Chemical compound CC=1C=C(C(=O)NCCS)C=CC1C QQIYDJPNFUIQMI-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RBABIWMICJIPOO-UHFFFAOYSA-N N-(2-sulfanylethyl)-3-(trifluoromethyl)benzamide Chemical compound FC(C=1C=C(C(=O)NCCS)C=CC=1)(F)F RBABIWMICJIPOO-UHFFFAOYSA-N 0.000 description 1
- 208000001649 Pica Diseases 0.000 description 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- ATADHKWKHYVBTJ-UHFFFAOYSA-N hydron;4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;chloride Chemical compound Cl.CNCC(O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-UHFFFAOYSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- FYQJUYCGPLFWQR-UHFFFAOYSA-N n-(2-chloroethyl)benzamide Chemical compound ClCCNC(=O)C1=CC=CC=C1 FYQJUYCGPLFWQR-UHFFFAOYSA-N 0.000 description 1
- JDJGNNHKOUXAKJ-UHFFFAOYSA-N n-(3-sulfanylpropyl)benzamide Chemical compound SCCCNC(=O)C1=CC=CC=C1 JDJGNNHKOUXAKJ-UHFFFAOYSA-N 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- HEPUEHGDWDOZJZ-UHFFFAOYSA-N o-(3-aminopropyl) benzenecarbothioate;hydrochloride Chemical compound Cl.NCCCOC(=S)C1=CC=CC=C1 HEPUEHGDWDOZJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- XJVIPPHGDPEDJL-UHFFFAOYSA-N thiourea;hydrochloride Chemical compound Cl.NC(N)=S XJVIPPHGDPEDJL-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93274878A | 1978-08-10 | 1978-08-10 | |
| US932,748 | 1978-08-10 | ||
| US462479A | 1979-01-18 | 1979-01-18 | |
| US4,624 | 1979-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1129881A true CA1129881A (en) | 1982-08-17 |
Family
ID=26673255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA333,426A Expired CA1129881A (en) | 1978-08-10 | 1979-08-09 | Benzamidoalkyl mercaptans |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL57859A (en) * | 1978-08-10 | 1983-02-23 | Robins Co Inc A H | Salts of benzene and thiophenecarbothioic acid 2-aminoalkyl esters and pharmaceutical compositions containing them |
| JPS63290860A (ja) * | 1987-05-22 | 1988-11-28 | Sanraku Inc | アミノエチルシステイン誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005222A (en) * | 1975-05-21 | 1977-01-25 | Mead Johnson & Company | Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process |
-
1979
- 1979-07-24 IL IL57881A patent/IL57881A/xx unknown
- 1979-08-03 CH CH716979A patent/CH641774A5/fr not_active IP Right Cessation
- 1979-08-08 GB GB7927693A patent/GB2028656B/en not_active Expired
- 1979-08-08 EG EG485/79A patent/EG14415A/xx active
- 1979-08-08 GB GB8204970A patent/GB2098596B/en not_active Expired
- 1979-08-08 IE IE1519/79A patent/IE48793B1/en unknown
- 1979-08-09 CA CA333,426A patent/CA1129881A/en not_active Expired
- 1979-08-09 FI FI792475A patent/FI69059C/fi not_active IP Right Cessation
- 1979-08-09 ES ES483270A patent/ES483270A1/es not_active Expired
- 1979-08-09 FR FR7920413A patent/FR2432868A1/fr active Granted
- 1979-08-09 DK DK333979A patent/DK333979A/da not_active Application Discontinuation
- 1979-08-09 IT IT68642/79A patent/IT1119136B/it active
- 1979-08-09 DE DE19792932403 patent/DE2932403A1/de active Granted
- 1979-08-10 AU AU49783/79A patent/AU526168B2/en not_active Ceased
- 1979-11-22 ES ES486226A patent/ES486226A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH641774A5 (fr) | 1984-03-15 |
| DE2932403C2 (enrdf_load_stackoverflow) | 1989-06-29 |
| GB2028656B (en) | 1983-03-09 |
| IL57881A (en) | 1982-12-31 |
| AU526168B2 (en) | 1982-12-23 |
| IE48793B1 (en) | 1985-05-15 |
| ES486226A1 (es) | 1980-06-16 |
| AU4978379A (en) | 1980-02-14 |
| FI69059B (fi) | 1985-08-30 |
| IL57881A0 (en) | 1979-11-30 |
| IE791519L (en) | 1980-02-10 |
| FR2432868A1 (fr) | 1980-03-07 |
| GB2028656A (en) | 1980-03-12 |
| ES483270A1 (es) | 1980-04-16 |
| FI792475A7 (fi) | 1980-02-11 |
| DE2932403A1 (de) | 1980-02-21 |
| FI69059C (fi) | 1985-12-10 |
| DK333979A (da) | 1980-02-11 |
| GB2098596A (en) | 1982-11-24 |
| FR2432868B1 (enrdf_load_stackoverflow) | 1981-07-17 |
| IT1119136B (it) | 1986-03-03 |
| EG14415A (en) | 1983-09-30 |
| IT7968642A0 (it) | 1979-08-09 |
| GB2098596B (en) | 1983-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2072986C1 (ru) | Способ получения амидов карбоновых или сульфоновых кислот или их физиологически совместимых солей | |
| PT94231A (pt) | Processo para a preparacao de compostos de ureia antihiperlipidemicos e anti-ateroscleroticos | |
| JPS6156167A (ja) | 薬学的に活性なピペラジノ誘導体及びその製造法 | |
| JP2002510320A (ja) | 新規な一酸化窒素放出アミジンおよびエナミン誘導ジアゼニウムジオレート、組成物およびそれらの用途、ならびにその製造方法 | |
| HU216191B (hu) | Eljárás új amidinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására | |
| KR850001884B1 (ko) | 수용성 벤조티아진 디옥시드염류의 제조방법 | |
| PT94305B (pt) | Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos | |
| PL117195B1 (en) | Method of manufacture of novel derivatives of pyrrolidinyl-or pyrrolidinylalkylbenzamidepirolidinilalkilbenzamida | |
| NZ260505A (en) | Cyclic indole derivatives and medicaments thereof | |
| CA1129881A (en) | Benzamidoalkyl mercaptans | |
| JPS609716B2 (ja) | １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用 | |
| CA1124250A (en) | Thiophenecarboxamido alkyl mercaptans | |
| EP0052910B1 (en) | Derivative of n-acetilcysteine having therapeutical activity, process for its preparation and related pharmaceutical compositions | |
| PL111745B1 (en) | Method of preparing of novel derivatives of amino acids | |
| PT95797A (pt) | Processo para a preparacao de novos derivados de arilcarbamatos com actividade inibidora da enzima aciltransferase de acil-coenzima a:colesterol (acat) | |
| IE64992B1 (en) | Substituted indoles | |
| EP0100815B1 (en) | N-(1,3-dithiolan-2-ylidene)anilines and their use as anti-inflammatory and anti-asthmatic agents | |
| CA1134273A (en) | Benzene and thiophene-carbothioic acid 2-aminoalkyl ester acid salts | |
| IE48794B1 (en) | Benzene and thiophene-carbothioic acid 2 aminoalkyl ester acid salts | |
| CA1072097A (en) | Process for the preparation of new thieno (3,2-c) pyridine derivatives | |
| US4296092A (en) | Mucolytic benzene and thiophene-carbothioic acid 2-aminoalkyl ester acid salts | |
| JPS5840544B2 (ja) | １−（２−（ｂ− ナフチルオキシ ）−エチル）−３− メチル − ピラゾロン −（５） ノセイゾウホウホウ | |
| JPS6361311B2 (enrdf_load_stackoverflow) | ||
| WO1995029155A1 (en) | Novel antitumour compounds with antimitotic activity | |
| PT643045E (pt) | Derivados de quinoleina como antagonistas de leucotrienos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |